HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed [Phase 3]
Phase 3 trial evaluating switching to fixed-dose combination B/F/TAF in virologically suppressed adults with HIV-1 infection.
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: The Safety, Pharmacokinetic Profile and Efficacy of Raltegravir in HIV-infected Patients at Least 60 Years of Age [Phase 4]
Phase 4 trial update on safety, pharmacokinetics, and efficacy of raltegravir in HIV-infected patients aged 60 and over.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant [Phase 4]
Phase 4 trial evaluating the impact of Everolimus on HIV persistence after kidney or liver transplant; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Genetics and HIV-1 Protease Inhibitors [Phase 4]
Phase 4 clinical trial update on genetics and HIV-1 protease inhibitors completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Switch to Maraviroc + Integrase Inhibitor [Phase 3]
Phase 3 clinical trial evaluating switching to maraviroc combined with an integrase inhibitor for HIV; trial status completed with results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: Genotypic Tropism Testing In Proviral Dna To Guide CCR5 Antagonist Treatment In Subjects With Undetectable HIV-1 Viremia [Phase 4]
Phase 4 clinical trial evaluating genotypic tropism testing in proviral DNA to guide CCR5 antagonist therapy in people with undetectable HIV…
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I [Phase 3]
A Phase 3 trial evaluating switching virologically suppressed HIV-1 patients with archived M184V/M184I mutations to an elvitegravir/cobicist…
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals [NA]
Clinical trial update on raltegravir CSF pharmacodynamics in HIV-infected individuals; study terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: The Maraviroc Darunavir/Ritonavir Once Daily Pharmacokinetic Study [Phase 1]
Phase 1 pharmacokinetic study of maraviroc with darunavir/ritonavir administered once daily in HIV patients has completed; results posted in…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Kinetics of HIV-RNA Decay in Seminal Plasma of Men Treated by Dolutegravir at the Time of Primary HIV Infection [Phase 3]
A Phase 3 trial evaluating the kinetics of HIV-RNA decay in seminal plasma of men treated with dolutegravir at the time of primary HIV infec…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Evaluation of the Effect of 3HP vs Periodic 3HP vs 6H in HIV-Positive Individuals [Phase 3]
Phase 3 trial evaluating 3HP regimens vs 6H in HIV-positive individuals with tuberculosis has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Single-Dose Study of MK-4250 Monotherapy in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-4250-002) [Phase 1]
Phase 1 single-dose safety and pharmacokinetics study of MK-4250 monotherapy in ART-naive HIV-1 infected participants; completed with result…
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: AmB Dose for Cryptococcal Meningitis [Phase 3]
Phase 3 trial update examining AmB dose for cryptococcal meningitis; status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure [Phase 4]
A Phase 4 clinical trial update on HIV diagnosis and treatment at birth for newborns with high-risk exposure, completed.
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: To Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection [NA]
Clinical trial assessing neuroinflammation and neurocognitive function in patients with acute hepatitis C and chronic HIV co-infection; stat…
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa [Phase 4]
Phase 4 trial comparing boosted atazanavir with Truvada vs boosted darunavir with maraviroc and Kivexa in treatment-naive HIV-1 subjects ass…
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Marginalized Populations Who Are Virologically Suppressed [Phase 4]
Phase 4 trial update evaluating switching to a fixed-dose combination of bictegravir/emtricitabine/tenofovir alafenamide in virologically su…
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: A Risky Sex Prevention Intervention for Middle School Age Minority Girls [NA]
A completed clinical trial from UNC Greensboro evaluating a risk reduction intervention for HIV prevention among middle school-age minority …
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Inducing Immune Quiescence to Prevent HIV Infection in Women [NA]
Clinical trial completed test of inducing immune quiescence to prevent HIV infection in women; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis [Phase 2]
Phase 2 study evaluating simtuzumab in adults with liver fibrosis and hepatitis C, including HIV co-infection; study completed with results …
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children [Phase 3]
Phase 3 trial update evaluating bronchopulmonary function response to azithromycin in chronic lung disease associated with HIV infection in …
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: The Health Access and Recovery Peer Program [NA]
Clinical trial update for the Health Access and Recovery Peer Program; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART [Phase 4]
Phase 4 clinical trial evaluating ER Niacin/Laropiprant impact on cardiovascular markers and atheroprogression in HIV-infected individuals o…
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria [Phase 4]
Phase 4 trial assessing the impact of cotrimoxazole use in immunocompetent HIV patients on carriage of antimicrobial-resistant bacteria.
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: HIV Adherence Bottle Intervention Trial [NA]
A completed clinical trial evaluating an adherence bottle intervention for people living with HIV-1 infection; results posted in 2019.